CHINA NATIONAL MEDICINE (600511.SS)
- Previous Close
30.79 - Open
30.68 - Bid 30.50 x --
- Ask 30.51 x --
- Day's Range
30.21 - 30.78 - 52 Week Range
27.12 - 38.00 - Volume
3,589,036 - Avg. Volume
4,329,517 - Market Cap (intraday)
23.012B - Beta (5Y Monthly) 0.56
- PE Ratio (TTM)
11.51 - EPS (TTM)
2.65 - Earnings Date --
- Forward Dividend & Yield 0.85 (2.80%)
- Ex-Dividend Date Jun 13, 2024
- 1y Target Est
--
China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.
www.cncm.com.cn3,104
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 600511.SS
View MorePerformance Overview: 600511.SS
Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 600511.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 600511.SS
View MoreValuation Measures
Market Cap
23.01B
Enterprise Value
15.02B
Trailing P/E
11.51
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.45
Price/Book (mrq)
1.31
Enterprise Value/Revenue
0.29
Enterprise Value/EBITDA
5.60
Financial Highlights
Profitability and Income Statement
Profit Margin
3.91%
Return on Assets (ttm)
3.87%
Return on Equity (ttm)
11.31%
Revenue (ttm)
51.19B
Net Income Avi to Common (ttm)
2B
Diluted EPS (ttm)
2.65
Balance Sheet and Cash Flow
Total Cash (mrq)
8.85B
Total Debt/Equity (mrq)
4.41%
Levered Free Cash Flow (ttm)
-439.49M